View in EDS

Impact of less invasive axillary staging procedures after neoadjuvant systemic therapy on adjuvant systemic therapy indications in HER2-positive and triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: Impact of less invasive axillary staging procedures after neoadjuvant systemic therapy on adjuvant systemic therapy indications in HER2-positive and triple-negative breast cancer.
Authors: Claassens EL; Department of Surgery, Maastricht University Medical Centre+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands. Electronic address: eva.claassens@maastrichtuniversity.nl., Koppert LB; Department of Surgical Oncology, Erasmus Medical Centre Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands., van der Pol CC; Department of Surgical Oncology, Cancer Centre, University Medical Centre Utrecht, Utrecht, the Netherlands; Department of Surgical Oncology, Alrijne Hospital, Leiderdorp, the Netherlands., Luiten EJT; Department of Surgical Oncology, Amphia Hospital, Breda, the Netherlands; Department of Surgery College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi Emirate, United Arab Emirates., van Nijnatten TJA; GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, Maastricht, the Netherlands., Jager A; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands., de Boer M; Division of Medical Oncology, Department of Internal Medicine, GROW - Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands., van Diest PJ; Department of Pathology, University Medical Centre Utrecht, Utrecht, the Netherlands., Smidt ML; Department of Surgery, Maastricht University Medical Centre+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands., Simons JM; GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands; Department of Radiotherapy, Erasmus Medical Centre Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Corporate Authors: RISAS study group
Source: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2026 Jun; Vol. 52 (6), pp. 111785. Date of Electronic Publication: 2026 Apr 03.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-2157
DOI:10.1016/j.ejso.2026.111785